Mass screening for early detection of hepatocellular carcinoma by setting a high-risk population with α-fetoprotein and its glycoforms

N. Rimal, S. Ikeda, K. Taketa, T. Kariya

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

We studied the usefulness of Lens culinaris agglutinin A-reactive α- fetoprotein (AFP)-L3 and erythroagglutinating phytohemagglutinin-reactive AFP-P4 as a tool for early detection of hepatocellular carcinoma (HCC) in a mass screening programme. Eight hundred and eight subjects from a total of 24839 subjects, who attended the mass screening for elderly were considered a high-risk group for HCC on the basis of abnormal aspartate aminotransferase (AST) serum levels and/or zinc sulphate turbidity test (ZTT). They were tested for serum AFP level, 33 examinees with serum AFP levels above 20 ng ml-1 were further screened by AFP-L3 and AFP-P4 analysis. Seven people were found to have AFP L-3 and or AFP P-4 above the cutoff values of 15 and 12%, respectively, and further evaluated as a population at extremely high-risk of having HCC. Five people were diagnosed with HCC and two people were followed up, the detection rate being 0.02%, which is comparable to that of ultrasound-based mass screening of HCC. Ultrasound scanning of the liver at the time of initial screening with liver function tests failed to detect space-occupying lesions of the liver. The cost of detecting one case of HCC was calculated at US $28 790, which is one-fourth of the cost of ordinary mass screening for HCC. Thus, the inclusion of the assay for AFP-L3 and AFP- P4 as well as AST, ZTT and AFP in mass screening for HCC was found highly cost effective.

Original languageEnglish
Pages (from-to)9-19
Number of pages11
JournalHepatology Research
Volume9
Issue number1
Publication statusPublished - Nov 1997

Fingerprint

Fetal Proteins
Mass Screening
Hepatocellular Carcinoma
Population
Zinc Sulfate
Aspartate Aminotransferases
Costs and Cost Analysis
Serum
Liver
Liver Function Tests

Keywords

  • AFP glycoforms
  • AST
  • Cost-effectiveness analysis
  • HCC
  • Mass screening
  • ZTT

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Mass screening for early detection of hepatocellular carcinoma by setting a high-risk population with α-fetoprotein and its glycoforms. / Rimal, N.; Ikeda, S.; Taketa, K.; Kariya, T.

In: Hepatology Research, Vol. 9, No. 1, 11.1997, p. 9-19.

Research output: Contribution to journalArticle

@article{ed93c03341864bf298cf50d393e10271,
title = "Mass screening for early detection of hepatocellular carcinoma by setting a high-risk population with α-fetoprotein and its glycoforms",
abstract = "We studied the usefulness of Lens culinaris agglutinin A-reactive α- fetoprotein (AFP)-L3 and erythroagglutinating phytohemagglutinin-reactive AFP-P4 as a tool for early detection of hepatocellular carcinoma (HCC) in a mass screening programme. Eight hundred and eight subjects from a total of 24839 subjects, who attended the mass screening for elderly were considered a high-risk group for HCC on the basis of abnormal aspartate aminotransferase (AST) serum levels and/or zinc sulphate turbidity test (ZTT). They were tested for serum AFP level, 33 examinees with serum AFP levels above 20 ng ml-1 were further screened by AFP-L3 and AFP-P4 analysis. Seven people were found to have AFP L-3 and or AFP P-4 above the cutoff values of 15 and 12{\%}, respectively, and further evaluated as a population at extremely high-risk of having HCC. Five people were diagnosed with HCC and two people were followed up, the detection rate being 0.02{\%}, which is comparable to that of ultrasound-based mass screening of HCC. Ultrasound scanning of the liver at the time of initial screening with liver function tests failed to detect space-occupying lesions of the liver. The cost of detecting one case of HCC was calculated at US $28 790, which is one-fourth of the cost of ordinary mass screening for HCC. Thus, the inclusion of the assay for AFP-L3 and AFP- P4 as well as AST, ZTT and AFP in mass screening for HCC was found highly cost effective.",
keywords = "AFP glycoforms, AST, Cost-effectiveness analysis, HCC, Mass screening, ZTT",
author = "N. Rimal and S. Ikeda and K. Taketa and T. Kariya",
year = "1997",
month = "11",
language = "English",
volume = "9",
pages = "9--19",
journal = "Hepatology Research",
issn = "1386-6346",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Mass screening for early detection of hepatocellular carcinoma by setting a high-risk population with α-fetoprotein and its glycoforms

AU - Rimal, N.

AU - Ikeda, S.

AU - Taketa, K.

AU - Kariya, T.

PY - 1997/11

Y1 - 1997/11

N2 - We studied the usefulness of Lens culinaris agglutinin A-reactive α- fetoprotein (AFP)-L3 and erythroagglutinating phytohemagglutinin-reactive AFP-P4 as a tool for early detection of hepatocellular carcinoma (HCC) in a mass screening programme. Eight hundred and eight subjects from a total of 24839 subjects, who attended the mass screening for elderly were considered a high-risk group for HCC on the basis of abnormal aspartate aminotransferase (AST) serum levels and/or zinc sulphate turbidity test (ZTT). They were tested for serum AFP level, 33 examinees with serum AFP levels above 20 ng ml-1 were further screened by AFP-L3 and AFP-P4 analysis. Seven people were found to have AFP L-3 and or AFP P-4 above the cutoff values of 15 and 12%, respectively, and further evaluated as a population at extremely high-risk of having HCC. Five people were diagnosed with HCC and two people were followed up, the detection rate being 0.02%, which is comparable to that of ultrasound-based mass screening of HCC. Ultrasound scanning of the liver at the time of initial screening with liver function tests failed to detect space-occupying lesions of the liver. The cost of detecting one case of HCC was calculated at US $28 790, which is one-fourth of the cost of ordinary mass screening for HCC. Thus, the inclusion of the assay for AFP-L3 and AFP- P4 as well as AST, ZTT and AFP in mass screening for HCC was found highly cost effective.

AB - We studied the usefulness of Lens culinaris agglutinin A-reactive α- fetoprotein (AFP)-L3 and erythroagglutinating phytohemagglutinin-reactive AFP-P4 as a tool for early detection of hepatocellular carcinoma (HCC) in a mass screening programme. Eight hundred and eight subjects from a total of 24839 subjects, who attended the mass screening for elderly were considered a high-risk group for HCC on the basis of abnormal aspartate aminotransferase (AST) serum levels and/or zinc sulphate turbidity test (ZTT). They were tested for serum AFP level, 33 examinees with serum AFP levels above 20 ng ml-1 were further screened by AFP-L3 and AFP-P4 analysis. Seven people were found to have AFP L-3 and or AFP P-4 above the cutoff values of 15 and 12%, respectively, and further evaluated as a population at extremely high-risk of having HCC. Five people were diagnosed with HCC and two people were followed up, the detection rate being 0.02%, which is comparable to that of ultrasound-based mass screening of HCC. Ultrasound scanning of the liver at the time of initial screening with liver function tests failed to detect space-occupying lesions of the liver. The cost of detecting one case of HCC was calculated at US $28 790, which is one-fourth of the cost of ordinary mass screening for HCC. Thus, the inclusion of the assay for AFP-L3 and AFP- P4 as well as AST, ZTT and AFP in mass screening for HCC was found highly cost effective.

KW - AFP glycoforms

KW - AST

KW - Cost-effectiveness analysis

KW - HCC

KW - Mass screening

KW - ZTT

UR - http://www.scopus.com/inward/record.url?scp=0031452047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031452047&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0031452047

VL - 9

SP - 9

EP - 19

JO - Hepatology Research

JF - Hepatology Research

SN - 1386-6346

IS - 1

ER -